Spyre Therapeutics (SYRE) Stock Chart & Stock Price History → What’s Really Next for America… (From Porter & Company) (Ad) Free SYRE Stock Alerts $37.80 +0.42 (+1.12%) (As of 05/16/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Spyre Therapeutics Stock Price Performance5 Day Performance+2.36%1 Month Performance+4.22%3 Month Performance+62.79%Year-To-Date Performance+75.65% Receive SYRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsInvest in the "Trojan Horse" of Alzheimer's TreatmentThis one tiny Micro-Cap is at the forefront of what may be the most significant development in healthcare since the discovery of antibiotics.Click here and learn how you can invest in this incredible opportunity>>> SYRE Stock Chart for Friday, May, 17, 2024 SYRE Chart by TradingView Spyre Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$37.38$37.80+1.12%$38.70$36.83282,967 shs$1.52 billion05/15/2024$39.29$37.38-4.86%$40.49$36.62299,261 shs$1.51 billion05/14/2024$37.00$39.29+6.19%$39.60$37.15400,034 shs$1.58 billion05/13/2024$36.93$37.00+0.19%$38.42$36.04274,676 shs$1.49 billion05/10/2024$35.19$36.93+4.94%$38.64$35.12429,293 shs$1.34 billion05/09/2024$33.02$35.19+6.57%$36.00$32.46185,724 shs$1.27 billion Get the Latest News and Ratings for SYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$34.24$33.02-3.56%$34.34$31.81245,076 shs$1.19 billion05/07/2024$35.77$34.24-4.28%$35.75$33.53186,999 shs$1.24 billion05/06/2024$35.78$35.77-0.03%$37.00$34.98208,175 shs$1.29 billion05/03/2024$36.27$35.78-1.35%$39.04$35.17196,819 shs$1.29 billion05/02/2024$33.87$36.27+7.09%$36.98$33.83389,590 shs$1.31 billion05/01/2024$33.03$33.87+2.54%$34.39$31.39670,894 shs$1.22 billion04/30/2024$34.89$33.03-5.33%$36.65$32.70489,375 shs$1.19 billion04/29/2024$33.56$34.89+3.96%$35.85$33.41361,275 shs$1.26 billion04/26/2024$32.47$33.56+3.36%$34.31$32.49225,965 shs$1.21 billion04/25/2024$32.99$32.47-1.58%$33.23$31.27233,607 shs$1.17 billion04/24/2024$34.25$32.99-3.68%$34.48$32.25203,859 shs$1.19 billion04/23/2024$33.30$34.25+2.87%$35.88$32.42201,520 shs$1.24 billion04/22/2024$32.41$33.30+2.73%$34.39$32.00261,719 shs$1.20 billion04/19/2024$35.58$32.41-8.91%$35.40$31.97395,418 shs$131.26 million04/18/2024$34.31$35.58+3.70%$36.67$33.58415,288 shs$144.10 million04/17/2024$36.27$34.31-5.40%$36.37$32.00547,628 shs$138.96 million04/16/2024$37.20$36.27-2.50%$38.03$35.86190,818 shs$146.86 million04/15/2024$37.49$37.20-0.77%$38.54$36.31251,497 shs$150.66 million04/12/2024$38.59$37.49-2.85%$40.83$37.42335,992 shs$151.83 million04/11/2024$38.69$38.59-0.26%$39.01$36.83263,172 shs$156.25 million04/10/2024$39.18$38.69-1.25%$39.75$35.63255,215 shs$156.69 million04/09/2024$37.13$39.18+5.52%$39.53$36.52348,079 shs$158.68 million04/08/2024$36.18$37.13+2.63%$38.07$35.91275,474 shs$150.38 million04/05/2024$35.38$36.18+2.26%$37.62$34.67162,709 shs$146.53 million04/04/2024$34.66$35.38+2.08%$36.67$34.74583,745 shs$143.29 million04/03/2024$34.31$34.66+1.02%$35.56$33.57485,299 shs$140.37 million04/02/2024$37.00$34.31-7.27%$38.99$34.12335,832 shs$138.96 million04/01/2024$37.93$37.00-2.45%$39.69$36.42181,049 shs$149.85 million03/29/2024$37.93$37.93$38.69$36.39951,529 shs$153.62 million03/28/2024$37.00$37.93+2.51%$38.69$36.39951,529 shs$153.62 million03/27/2024$37.61$37.00-1.62%$38.10$36.49573,300 shs$149.85 million03/26/2024$38.48$37.61-2.26%$40.79$37.57327,867 shs$155.80 million03/25/2024$41.20$38.48-6.60%$43.00$37.99456,371 shs$155.84 million03/22/2024$39.86$41.20+3.36%$42.43$39.62302,064 shs$166.86 millionWhat’s Really Next for America… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.03/21/2024$39.76$39.86+0.25%$42.78$38.53396,798 shs$161.43 million03/20/2024$38.39$39.76+3.57%$40.33$37.41314,474 shs$161.03 million03/19/2024$40.07$38.39-4.19%$41.02$37.63957,323 shs$155.48 million03/18/2024$45.37$40.07-11.68%$47.97$39.60497,812 shs$162.28 million03/15/2024$41.92$45.37+8.23%$47.61$41.002.23 million shs$183.75 million03/14/2024$44.51$41.92-5.82%$44.74$41.04386,088 shs$169.78 million03/13/2024$42.32$44.51+5.17%$45.82$42.55295,269 shs$180.27 million03/12/2024$40.89$42.32+3.50%$42.45$39.39176,809 shs$171.35 million03/11/2024$37.93$40.89+7.80%$41.65$35.93507,267 shs$165.60 million03/08/2024$38.85$37.93-2.37%$41.01$37.38382,148 shs$153.62 million03/07/2024$40.26$38.85-3.50%$41.09$38.05551,952 shs$157.34 million03/06/2024$37.65$40.26+6.93%$40.81$36.15869,527 shs$163.05 million03/05/2024$34.97$37.65+7.66%$39.77$36.291.76 million shs$152.48 million03/04/2024$29.90$34.97+16.96%$35.35$30.901.31 million shs$141.63 million03/01/2024$27.44$29.90+8.97%$32.99$28.481.00 million shs$121.10 million02/29/2024$26.10$27.44+5.13%$28.80$24.851.17 million shs$111.13 million02/28/2024$24.91$26.10+4.78%$26.32$24.35383,095 shs$105.71 million02/27/2024$24.00$24.91+3.79%$24.91$23.62763,016 shs$100.86 million02/26/2024$23.58$24.00+1.78%$24.77$23.05969,710 shs$97.20 million02/23/2024$20.41$23.58+15.53%$23.74$20.13739,681 shs$95.50 million02/22/2024$20.48$20.41-0.34%$21.19$20.07207,135 shs$82.66 million02/21/2024$21.95$20.48-6.70%$21.91$20.12225,172 shs$82.94 million02/20/2024$23.22$21.95-5.47%$23.37$21.39296,163 shs$88.90 million02/19/2024$23.22$23.22$23.75$22.43996,500 shs$94.04 million02/16/2024$22.56$23.22+2.93%$23.74$22.50996,524 shs$94.04 million02/15/2024$22.54$22.56+0.09%$22.96$22.16236,220 shs$91.37 million Related Companies: TARO Stock Chart SUPN Stock Chart KURA Stock Chart RCUS Stock Chart EWTX Stock Chart LGND Stock Chart GPCR Stock Chart SDGR Stock Chart HRMY Stock Chart AVDL Stock Chart Receive SYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SYRE) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.